{
  "docId": "019de515-fc5e-76ca-8883-dafdda1b8616",
  "docSlug": "fc6386684027a59abf9ad1908a49f4e4",
  "documentTitle": "Nemaura Medical | Investor Presentation Deck | 22 slides",
  "authorId": "nemaura-medical",
  "authorName": "Nemaura Medical",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de515-fc5e-76ca-8883-dafdda1b8616/5",
  "deckHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616",
  "deckJsonHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616.json",
  "deckAnchorHref": "/decks/019de515-fc5e-76ca-8883-dafdda1b8616#slide-5",
  "components": [
    {
      "bbox": {
        "h": 1,
        "w": 1,
        "x": 0,
        "y": 0
      },
      "kind": "image",
      "text": "Photo of the glucose sensor and a pen.",
      "attrs": {},
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "346f020b-823a-40cf-8c50-ea7014041e9d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.27,
        "x": 0.699,
        "y": 0.69
      },
      "kind": "list",
      "text": "Consumer market: Pre-diabetes and Obesity: >90 million people¹ in USA",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f219d7f-f447-4be7-a4f6-285944597daa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.27,
        "x": 0.699,
        "y": 0.57
      },
      "kind": "list",
      "text": "Clinical Market: Type 2 diabetes: >60 million people in Europe²",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a9092600-039e-417e-8ff8-4bb5ecdcaf7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.14,
        "w": 0.27,
        "x": 0.699,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "To address this, we developed a Non-invasive daily wear continuous Glucose sensor targeting:",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d155c1e9-3ad7-4653-978c-4d3531fe3a8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.27,
        "x": 0.699,
        "y": 0.82
      },
      "kind": "source-note",
      "text": "[This market is currently deemed to be the largest opportunity for Nemaura]",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c8f41ec7-5b73-40bf-83cb-acc359297a36",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "185215d1-9cf9-40c1-91f0-e40c1c06bbce",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "slide 5 presents the solution",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "80f436de-8817-4094-ae88-7a83261a3a6a",
      "evidence": "slides 4-5 imply the consequences of not addressing glucose monitoring",
      "position": 0,
      "objective": "What is the cost of not using Nemaura Medical's solution?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 14,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "99db37b7-60e2-4606-9848-cb0be6231906",
      "evidence": "slides 5-14 explain the solution and its advantages",
      "position": 1,
      "objective": "How does Nemaura Medical's solution work and what are its benefits?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}